pirfenidone

Esbriet · ATC code L04AX05

Also known as: Pirfenidon · Brand names: Esbriet, Pirfenidon Accord, Pirfenidon Actavis, Pirfenidon Ratiopharm, Equitor, Pirfenair, Pirfenidon Al, Pirfenidon Amarox, Pirfenidon Axiromed, Pirfenidon Axunio, Pirfenidon Beta, Pirfenidon Cipla, Pirfenidon Glenmark, Pirfenidon Hormosan, Pirfenidon Intas …

Key facts
Active substance
pirfenidone
Drug class
Immunosuppressive drug
ATC code
L04AX05
Authorisation
centrally authorised across the EU (EMA)
Dosage forms
Esbriet 267 mg film-coated tablets / Esbriet 534 mg film-coated tablets / Esbriet 801 mg film-coated tablets
Marketing authorisation holder
H.A.C. Pharma
Information as of
2026-10-27

Key facts

Pirfenidone (Esbriet) is an oral medicine used to treat idiopathic pulmonary fibrosis (IPF) in adults.

What it is used for

  • Idiopathic pulmonary fibrosis (IPF) in adults

Dosing

  • Titrate over 14 days: days 1 to 7 267 mg three times a day, days 8 to 14 534 mg three times a day, day 15 onward 801 mg three times a day
  • Maintenance 801 mg three times a day with food (2403 mg/day); higher doses not recommended
  • After missing 14 consecutive days or more, re-titrate
  • For GI intolerance, photosensitivity or transaminase elevation, reduce or interrupt per the product information
  • No dose adjustment in patients 65 years and older

Contraindications

  • Hypersensitivity to the active substance or excipients; history of angioedema with pirfenidone
  • Concomitant fluvoxamine
  • Severe hepatic impairment or end-stage liver disease
  • Severe renal impairment (CrCl <30 ml/min) or end-stage renal disease requiring dialysis

Important warnings

  • Elevated transaminases are common; test liver function before starting, monthly for the first 6 months, then every 3 months
  • Severe drug-induced liver injury, including isolated fatal cases, has been reported
  • Photosensitivity and rash: use sunblock daily and avoid sun exposure

Side effects

  • Most frequent: nausea (32.4%), rash (26.2%), decreased appetite (20.7%), diarrhoea (18.8%), fatigue (18.5%), dyspepsia (16.1%)
  • Headache (10.1%), photosensitivity reaction (9.3%)
  • Very common upper respiratory tract infection; common urinary tract infection

Interactions

  • Pirfenidone is mainly metabolised via CYP1A2
  • Fluvoxamine (strong CYP1A2 inhibitor) greatly increases exposure and is contraindicated
  • Avoid grapefruit juice during treatment

Pregnancy and breastfeeding

  • No data in pregnant women; as a precaution, preferable to avoid in pregnancy

Summary of the official product information, written with AI (Claude, Anthropic) on 2026-10-28. Every number was checked automatically against the original text. Not reviewed by a physician – the full official text is authoritative.

Full official text →

Common questions – ask Medelix

For patients

Package leaflet, verbatim

Package leaflet for patients →

Authorisation and brand names by country

Medicines with exactly this active-substance composition, as listed in the national registers – alphabetical and without ranking. Whether a product is currently available is not shown here.

EU – centrally authorised (all member states)

Source: European Medicines Agency (EMA), product information

Austria

  • Pirfenidon AccordAccord Healthcare B.V. · 1 register entry
  • Pirfenidon ActavisActavis Group Ptc Ehf. · 1 register entry
  • Pirfenidon RatiopharmRatiopharm Arzneimittel Vertriebs-Gmbh · 1 register entry

Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28

Germany

  • EquitorStada Arzneimittel Ag · 1 register entry
  • PirfenairHexal Ag · 1 register entry
  • Pirfenidon AccordAccord Healthcare B.V. · 1 register entry
  • Pirfenidon AlAliud Pharma Gmbh · 1 register entry
  • Pirfenidon AmaroxAmarox Pharma Gmbh · 1 register entry
  • Pirfenidon AxiromedMedical Valley Invest Ab · 2 register entries
  • Pirfenidon AxunioAxunio Pharma Gmbh · 1 register entry
  • Pirfenidon BetaBetapharm Arzneimittel Gmbh · 1 register entry
  • Pirfenidon CiplaCipla Europe Nv · 1 register entry
  • Pirfenidon GlenmarkGlenmark Arzneimittel Gmbh · 1 register entry
  • Pirfenidon HormosanHormosan Pharma Gmbh · 1 register entry
  • Pirfenidon IntasIntas Third Party Sales 2005, S.L. · 1 register entry
Show all 18 brand names
  • Pirfenidon PurenPuren Pharma Gmbh & Co. Kg · 1 register entry
  • Pirfenidon RatiopharmRatiopharm Gmbh · 1 register entry
  • Pirfenidon StadaStadapharm Gmbh · 1 register entry
  • Pirfenidon UmedicaUmedica Netherlands B.V · 1 register entry
  • Pirfenidon VivantaVivanta Generics S.R.O. · 1 register entry
  • Pirfenidon ZentivaZentiva Pharma Gmbh · 1 register entry

Source: EMA – Article 57 product data (EU/EEA), as of 2026-10-28

Turkey

  • EsbrietROCHE MÜSTAHZARLARI SAN.A.Ş. · 2 register entries
  • MontenidonMONTERO İLAÇ VE GIDA SAN. VE TİC. A.Ş. · 2 register entries
  • PirfaALİ RAİF İLAÇ SAN. A.Ş. · 3 register entries
  • PirfectNOBEL İLAÇ SAN. VE TİC. A.Ş. · 5 register entries

Source: TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, as of 2026-10-16

Brand names in 28 more European countries
Belgium
Perfenidon Eg, Pirfenidon Cipla, Pirfenidon Eg, Pirfenidone Ab, Pirfenidone Accord
Bulgaria
Fredalix
Croatia
Pirfenidon Accord, Pirfenidon Sandoz, Pirfenidon Teva, Pirfenidone Accord, Pirfenidone Msn
Cyprus
Pirfenidone Accord, Pirfenidone Msn, Pirfenidone Tecnigen
Czechia
Fredalix, Pirfenidon Zentiva, Pirfenidone Accord, Pirfenidone Msn, Pirfenidone Teva, Pirfenidone Umedica
Denmark
Fredalix, Pirfenair, Pirfenidon Medical Valley, Pirfenidon Teva, Pirfenidon Zentiva, Pirfenidone "sandoz", Pirfenidone Accord, Pirfenidone Glenmark, Pirfenidone Newbury, Pirfenidone Stada
Estonia
Pirfenidone Accord, Pirfenidone Msn, Pirfenidone Teva, Pirfenidone Zentiva
Finland
Pirfenidon Cipla, Pirfenidone Accord, Pirfenidone Glenmark, Pirfenidone Ratiopharm, Pirfenidone Sandoz, Pirfenidone Stada
France
Pirfenidon Eg Labo - Laboratoireseurogenerics, Pirfenidone Accord, Pirfenidone Arrow, Pirfenidone Biogaran, Pirfenidone Cipla, Pirfenidone Eg, Pirfenidone Sandoz, Pirfenidone Teva, Pirfenidone Zentiva, Pirfenidone Zydus
Greece
Orepir, Pirfenidone Accord, Pirfenidone Sandoz, Pirfenidone Teva
Hungary
Pirfenidon Zentiva
Iceland
Esbriet, Pirfenidon Medical Valley, Pirfenidon Teva, Pirfenidon Zentiva, Pirfenidone Viatris
Ireland
Pirfenidone Accord, Pirfenidone Axunio, Pirfenidone Cipla, Pirfenidone Clonmel, Pirfenidone Msn, Pirfenidone Rowex, Pirfenidone Teva
Italy
Blamonehel, Pirfenidone Accord, Pirfenidone Aurobindo, Pirfenidone Cipla, Pirfenidone Dr. Reddy’s, Pirfenidone Eg, Pirfenidone Sandoz, Pirfenidone Tecnigen, Pirfenidone Teva, Pirfenidone Zentiva
Latvia
Pirfenidone Accord, Pirfenidone Msn, Pirfenidone Teva, Pirfenidone Umedica, Pirfenidone Zentiva
Liechtenstein
Esbriet, Pirfenidone Viatris
Lithuania
Pirfenidone Accord, Pirfenidone Msn, Pirfenidone Teva, Pirfenidone Zentiva
Luxembourg
Pirfenidon Eg
Malta
Pirfenidone Clonmel, Pirfenidone Msn
Netherlands
Pirfenidon Accord, Pirfenidon Amarox, Pirfenidon Axunio, Pirfenidon Glenmark, Pirfenidon Msn, Pirfenidon Sandoz, Pirfenidon Teva, Pirfenidon Vivanta, Pirfenidon Xiromed, Pirfenidone Aurobindo
Norway
Esbriet, Pirfenidon Cipla, Pirfenidon Koanaa, Pirfenidon Medical Valley, Pirfenidon Teva, Pirfenidon Zentiva, Pirfenidone Accord, Pirfenidone Glenmark, Pirfenidone Koanaa, Pirfenidone Newbury, Pirfenidone Sandoz, Pirfenidone Stada, Pirfenidone Viatris, Pirfenidone Vivanta
Poland
Pirfenidon Cipla Europe, Pirfenidon Medical Valley, Pirfenidon Msn, Pirfenidon Stada, Pirfenidon Zentiva, Pirfenidone Accord, Pirfenidone Aurovitas, Pirfenidone Sandoz
Portugal
Pirfenidona Accord, Pirfenidona Generis, Pirfenidona Pentafarma, Pirfenidona Sandoz, Pirfenidona Tecnigen, Pirfenidona Teva, Pirfenidona Vivanta
Romania
Pirfenidon Msn
Slovakia
Pirfenidone Msn, Pirfenidón Accord
Slovenia
Pirfenidon Accord, Pirfenidon Teva
Spain
Pirfenidona Accord, Pirfenidona Aurovitas, Pirfenidona Cipla, Pirfenidona Dr. Reddys, Pirfenidona Glenmark, Pirfenidona Kern Pharma, Pirfenidona Sandoz, Pirfenidona Tarbis, Pirfenidona Tecnigen, Pirfenidona Teva, Pirfenidona Umedica, Pirfenidona Vivanta, Pirfenidona Zentiva
Sweden
Pirfenidon Cipla, Pirfenidon Medical Valley, Pirfenidon Teva, Pirfenidon Zentiva, Pirfenidone Accord, Pirfenidone Glenmark, Pirfenidone Newbury, Pirfenidone Sandoz, Pirfenidone Stada, Pirfenidone Vivanta

EMA – Article 57 product data (EU/EEA), 2026-10-28

Medelix receives no money from pharmaceutical companies. Brand names are listed alphabetically and without ranking.

Other substances in the same group

Another question about this substance?

Medelix answers clinical questions from guidelines, studies and product information – every claim with its source.

Sources

  1. European Medicines Agency. Esbriet – EPAR, Product Information (OF THE TEXT Detailed information on this medicinal product i). 2026-10-27. https://www.ema.europa.eu/en/documents/product-information/esbriet-epar-product-information_en.pdf
  2. EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
  3. EMA – Article 57 product data (EU/EEA), 2026-10-28. https://www.ema.europa.eu/en/human-regulatory-overview/post-authorisation/data-medicines-iso-idmp-standards-post-authorisation/public-data-article-57-database
  4. TİTCK – Ruhsatlı Beşeri Tıbbi Ürünler Listesi, 2026-10-16. https://www.titck.gov.tr/dinamikmodul/85
  5. Wikidata (CC0): ATC L04AX.

Editorial: Medelix editorial team · last updated 2026-10-27 · How these pages are made · Report an error

Source: European Medicines Agency (EMA), product information. Not advertising, not a treatment recommendation. For questions about your own treatment, ask your doctor or pharmacist.